Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM150 in elective total hip replacement surgery
NCT00913120Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of darexaban in venous thromboembolism (VTE), sponsored by Astellas Pharma. Started May 2009; status: completed.
02
Drugs
darexaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00913120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913120.